Compounds > erlotinib
Page last updated: 2024-09-05

erlotinib and 3',4'-dihydroxyaurone

erlotinib has been researched along with 3',4'-dihydroxyaurone in 1 studies

Compound Research Comparison

Studies
(erlotinib)		Trials
(erlotinib)		Recent Studies (post-2010)
(erlotinib)		Studies
(3',4'-dihydroxyaurone)		Trials
(3',4'-dihydroxyaurone)		Recent Studies (post-2010) (3',4'-dihydroxyaurone)
2210180504

Protein Interaction Comparison

ProteinTaxonomyerlotinib (IC50)3',4'-dihydroxyaurone (IC50)
Histone deacetylase 3Homo sapiens (human)8.2
Serine/threonine-protein kinase 17BHomo sapiens (human)3.08
Histone deacetylase 4Homo sapiens (human)8.2
Histone deacetylase 1Homo sapiens (human)8.2
Histone deacetylase 7Homo sapiens (human)8.2
Histone deacetylase 2Homo sapiens (human)6.65
Polyamine deacetylase HDAC10Homo sapiens (human)8.2
Histone deacetylase 11 Homo sapiens (human)8.2
Histone deacetylase 8Homo sapiens (human)8.2
Histone deacetylase 6Homo sapiens (human)8.2
Histone deacetylase 9Homo sapiens (human)8.2
Histone deacetylase 5Homo sapiens (human)8.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, MJ; Alsayari, A; Alshehri, JA; Begum, N; Hassan, MZ; Muhsinah, AB1

Reviews

1 review(s) available for erlotinib and 3',4'-dihydroxyaurone

ArticleYear
Aurone: A biologically attractive scaffold as anticancer agent.
    European journal of medicinal chemistry, 2019, Mar-15, Volume: 166

    Topics: Animals; Antineoplastic Agents; Benzofurans; Drug Discovery; Humans

2019